The potential role of DNA methylation in the pathogenesis of abdominal aortic aneurysm

Atherosclerosis

Volumn 241, Issue 1, 2015, Pages 121-129

  Toghill, Bradley J ^a   Saratzis, Athanasios ^a   Harrison, Seamus C ^a   Verissimo, Ana R ^a   Mallon, Eamonn B ^a   Bown, Matthew J ^a  

^a UNIVERSITY OF LEICESTER   (United Kingdom)

Author keywords

Abdominal aortic aneurysm; Cardiovascular disease; DNA methylation; Epigenome wide association; Inflammation; Matrix metalloproteinase

Indexed keywords

ABDOMINAL AORTA; ABDOMINAL AORTA ANEURYSM; AGING; ATHEROSCLEROSIS; CARDIOVASCULAR RISK; CAUCASIAN; DNA METHYLATION; DNA MODIFICATION; ENVIRONMENTAL FACTOR; EPIGENETICS; GENETIC ASSOCIATION; GENETIC TRANSCRIPTION; HEREDITY; HUMAN; HYPERTENSION; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; SEX DIFFERENCE; SMOKING; ADVERSE EFFECTS; AGE; ANIMAL; AORTIC ANEURYSM, ABDOMINAL; CPG ISLAND; GENETIC EPIGENESIS; GENETIC PREDISPOSITION; GENETICS; LESIONS AND DEFECTS; METABOLISM; PATHOLOGY; PHENOTYPE; PROGNOSIS; RISK FACTOR;

AGE FACTORS; AGING; ANIMALS; AORTA, ABDOMINAL; AORTIC ANEURYSM, ABDOMINAL; CPG ISLANDS; DILATATION, PATHOLOGIC; DNA METHYLATION; EPIGENESIS, GENETIC; GENETIC PREDISPOSITION TO DISEASE; HUMANS; PHENOTYPE; PROGNOSIS; RISK FACTORS; SMOKING;

EID: 84983111414     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2015.05.001     Document Type: Review

References (97)

1. Abraha I., Romagnoli C., Montedori A., et al. Thoracic stent graft versus surgery for thoracic aneurysm. Cochrane Database Syst. Rev. 2009, Cd006796.
2. Lu H., Rateri D.L., Bruemmer D., et al. Novel mechanisms of abdominal aortic aneurysms. Curr. Atheroscler. Rep. 2012, 14:402-412.
3. Earnshaw J.J. Triumphs and tribulations in a new national screening programme for abdominal aortic aneurysm. Acta Chir. Belg. 2012, 112:108-110.
4. Thompson S.G., Ashton H.A., Gao L., et al. Screening men for abdominal aortic aneurysm: 10 year mortality and cost effectiveness results from the randomised multicentre aneurysm screening Study. BMJ 2009, 338:b2307.
5. Moll F.L., Powell J.T., Fraedrich G., et al. Management of abdominal aortic aneurysms clinical practice guidelines of the European society for vascular surgery. Eur. J. Vasc. Endovasc. Surg. 2011, 41(Suppl. 1):S1-s58.
6. Kuivaniemi H., Ryer E.J., Elmore J.R., et al. Update on abdominal aortic aneurysm research: from clinical to genetic studies. Sci. (Cairo) 2014, 2014:564734.
7. Harrison S.C., Kalea A.Z., Holmes M.V., et al. Genomic research to identify novel pathways in the development of abdominal aortic aneurysm. Cardiol. Res. Pract. 2012, 2012:852829.
8. Saratzis A., Bown M.J. The genetic basis for aortic aneurysmal disease. Heart (Br. Card. Soc.) 2014, 100:916-922.
9. Bown M.J., Sweeting M.J., Brown L.C., et al. Surveillance intervals for small abdominal aortic aneurysms: a meta-analysis. JAMA 2013, 309:806-813.
10. Liyanage V.R., Jarmasz J.S., Murugeshan N., et al. DNA modifications: function and applications in normal and disease States. Biol. (Basel) 2014, 3:670-723.
11. Zaina S., Heyn H., Carmona F.J., et al. A DNA methylation map of human atherosclerosis, circulation. Cardiovasc. Genet. 2014, 7(5):692-700.
12. Participants, TUSAT Mortality results for randomised controlled trial of early elective surgery or ultrasonographic surveillance for small abdominal aortic aneurysms. The UK small aneurysm trial participants. Lancet 1998, 352:1649-1655.
13. Davis F.M., Rateri D.L., Daugherty A. Mechanisms of aortic aneurysm formation: translating preclinical studies into clinical therapies. Heart (Br. Card. Soc. 2014, 100:1498-1505.
14. Campbell W.B. Mortality statistics for elective aortic aneurysms. Eur. J. Vasc. Surg. 1991, 5:111-113.
15. Participants, UKSAT Long-term outcomes of immediate repair compared with surveillance of small abdominal aortic aneurysms. N. Engl. J. Med. 2002, 346:1445-1452.
16. Svensjo S., Bjorck M., Gurtelschmid M., et al. Low prevalence of abdominal aortic aneurysm among 65-year-old Swedish men indicates a change in the epidemiology of the disease. Circulation 2011, 124:1118-1123.
17. Earnshaw J.J., Shaw E., Whyman M.R., et al. Screening for abdominal aortic aneurysms in men. BMJ 2004, 328:1122-1124.
18. Eckroth-Bernard K., Garvin R., Ryer E. Current status of endovascular devices to treat abdominal aortic aneurysms. Biomed. Eng. Comput Biol. 2013, 5:25-32.
19. Holt P.J., Poloniecki J.D., Gerrard D., et al. Meta-analysis and systematic review of the relationship between volume and outcome in abdominal aortic aneurysm surgery. Br. J. Surg. 2007, 94:395-403.
20. Ketelsen D., Thomas C., Schmehl J., et al. Endovascular aneurysm repair of abdominal aortic aneurysms: standards, technical options and advanced indications. RoFo 2014, 186:337-347. Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin.
21. Saratzis A., Abbas A.A., Kiskinis D., et al. Abdominal aortic aneurysm: a review of the genetic basis. Angiology 2011, 62:18-32.
22. Wahlgren C.M., Larsson E., Magnusson P.K., et al. Genetic and environmental contributions to abdominal aortic aneurysm development in a twin population. J. Vasc. Surg. 2010, 51:3-7. discussion 7.
23. Golledge J., Kuivaniemi H. Genetics of abdominal aortic aneurysm. Curr. Opin. Cardiol. 2013, 28:290-296.
24. Kuivaniemi H., Elmore J.R. Opportunities in abdominal aortic aneurysm research: epidemiology, genetics, and pathophysiology. Ann. Vasc. Surg. 2012, 26:862-870.
25. Majumder P.P., St Jean P.L., Ferrell R.E., et al. On the inheritance of abdominal aortic aneurysm. Am. J. Hum. Genet. 1991, 48:164-170.
26. Powell J.T., Greenhalgh R.M. Multifactorial inheritance of abdominal aortic aneurysm. Eur. J. Vasc. Surg. 1987, 1:29-31.
27. Bown M.J., Jones G.T., Harrison S.C., et al. Abdominal aortic aneurysm is associated with a variant in low-density lipoprotein receptor-related protein 1. Am. J. Hum. Genet. 2011, 89:619-627.
28. Jones G.T., Bown M.J., Gretarsdottir S., et al. A sequence variant associated with sortilin-(SORT1) on 1p13.3 is independently associated with abdominal aortic aneurysm. Hum. Mol. Genet. 2013, 22:2941-2947.
29. Bradley D.T., Hughes A.E., Badger S.A., et al. A variant in LDLR is associated with abdominal aortic aneurysm. Circ. Cardiovasc. Genet. 2013, 6:498-504.
30. Goldberg A.D., Allis C.D., Bernstein E. Epigenetics: a landscape takes shape. Cell 2007, 128:635-638.
31. Conaway J.W. Introduction to theme "Chromatin, epigenetics, and transcription. Annu. Rev. Biochem. 2012, 81:61-64.
32. Roth T.L., Sweatt J.D. Annual research review: epigenetic mechanisms and environmental shaping of the brain during sensitive periods of development. J. Child Psychol. Psychiatry Allied Discip. 2011, 52:398-408.
33. Jaenisch R., Bird A. Epigenetic regulation of gene expression: how the genome integrates intrinsic and environmental signals. Nat. Genet. 2003, 33:245-254.
34. Clark C., Palta P., Joyce C.J., et al. A comparison of the whole genome approach of MeDIP-seq to the targeted approach of the infinium HumanMethylation450 BeadChip((R)) for methylome profiling,. PLoS One 2012, 7:e50233.
35. Michels K.B., Binder A.M., Dedeurwaerder S., et al. Recommendations for the design and analysis of epigenome-wide association studies. Nat. Methods 2013, 10:949-955.
36. Bannister A.J., Kouzarides T. Regulation of chromatin by histone modifications. Cell Res. 2011, 21:381-395.
37. Jeltsch A. Reading and writing DNA methylation. Nat. Struct. Mol. Biol. 2008, 15:1003-1004.
38. Bird A. DNA methylation patterns and epigenetic memory. Genes Dev. 2002, 16:6-21.
39. Tsaprouni L.G., Yang T.P., Bell J., et al. Cigarette smoking reduces DNA methylation levels at multiple genomic loci but the effect is partially reversible upon cessation. Epigenet. Off. J. DNA Methylation Soc. 2014, 9:1382-1396.
40. Glier M.B., Green T.J., Devlin A.M. Methyl nutrients, DNA methylation, and cardiovascular disease. Mol. Nutr. Food Res. 2014, 58:172-182.
41. Wongtrakoongate P. Epigenetic therapy of cancer stem and progenitor cells by targeting DNA methylation machineries. World J. Stem Cells 2015, 7:137-148.
42. Egger G., Liang G., Aparicio A., et al. Epigenetics in human disease and prospects for epigenetic therapy. Nature 2004, 429:457-463.
43. Kawasaki H., Taira K. Induction of DNA methylation and gene silencing by short interfering RNAs in human cells. Nature 2004, 431:211-217.
44. Cao Q., Wang X., Jia L., et al. Inhibiting DNA methylation by 5-aza-2'-deoxycytidine ameliorates atherosclerosis through suppressing macrophage inflammation. Endocrinology 2014, 155:4925-4938.
45. Yang X., Han H., De Carvalho D.D., et al. Gene body methylation can alter gene expression and is a therapeutic target in cancer. Cancer Cell 2014, 26:577-590.
46. Robertson A.K., Geiman T.M., Sankpal U.T., et al. Effects of chromatin structure on the enzymatic and DNA binding functions of DNA methyltransferases DNMT1 and Dnmt3a in vitro. Biochem. Biophys. Res. Commun. 2004, 322:110-118.
47. Chuang L.S., Ian H.I., Koh T.W., et al. Human DNA-(cytosine-5) methyltransferase-PCNA complex as a target for p21WAF1. Sci. (N. Y., N. Y.) 1997, 277:1996-2000.
48. Kroeze, LI, van der Reijden, BA and Jansen, JH, 5-Hydroxymethylcytosine: an epigenetic mark frequently deregulated in cancer, Biochim. Biophys. Acta (BBA) - Rev. Cancer 1855 (2), 144-154.
49. Drong A.W., Nicholson G., Hedman A.K., et al. The presence of methylation quantitative trait loci indicates a direct genetic influence on the level of DNA methylation in adipose tissue,. PLoS One 2013, 8:e55923.
50. Zhi D., Aslibekyan S., Irvin M.R., et al. SNPs located at CpG sites modulate genome-epigenome interaction. Epigenet. Off. J. DNA Methylation Soc. 2013, 8:802-806.
51. Robertson K.D. DNA methylation and human disease, nature reviews. Genetics 2005, 6:597-610.
52. Marian A.J., Belmont J. Strategic approaches to unraveling genetic causes of cardiovascular diseases. Circ. Res. 2011, 108:1252-1269.
53. Wang X., Falkner B., Zhu H., et al. A genome-wide methylation study on essential hypertension in young African American males,. PLoS One 2013, 8:e53938.
54. Hur K., Han T.S., Jung E.J., et al. Up-regulated expression of sulfatases (SULF1 and SULF2) as prognostic and metastasis predictive markers in human gastric cancer. J. Pathol. 2012, 228:88-98.
55. Baccarelli A., Wright R., Bollati V., et al. Ischemic heart disease and stroke in relation to blood DNA methylation. Epidemiol. (Camb. Mass) 2010, 21:819-828.
56. Krishna S.M., Dear A., Craig J.M., et al. The potential role of homocysteine mediated DNA methylation and associated epigenetic changes in abdominal aortic aneurysm formation,. Atherosclerosis 2013, 228:295-305.
57. Krishna S.M., Dear A.E., Norman P.E., et al. Genetic and epigenetic mechanisms and their possible role in abdominal aortic aneurysm. Atherosclerosis 2010, 212:16-29.
58. Diehm N., Dick F., Schaffner T., et al. Novel insight into the pathobiology of abdominal aortic aneurysm and potential future treatment concepts. Prog. Cardiovasc. Dis. 2007, 50:209-217.
59. Ailawadi G., Knipp B.S., Lu G., et al. A nonintrinsic regional basis for increased infrarenal aortic MMP-expression and activity,. J. Vasc. Surg. 2003, 37:1059-1066.
60. Pearce W.H., Shively V.P. Abdominal aortic aneurysm as a complex multifactorial disease: interactions of polymorphisms of inflammatory genes, features of autoimmunity, and current status of MMPs. Ann. N. Y. Acad. Sci. 2006, 1085:117-132.
61. Dobrin P.B., Mrkvicka R. Failure of elastin or collagen as possible critical connective tissue alterations underlying aneurysmal dilatation. Cardiovasc. Surg. Lond. Engl. 1994, 2:484-488.
62. Wassef M., Baxter B.T., Chisholm R.L., et al. Pathogenesis of abdominal aortic aneurysms: a multidisciplinary research program supported by the National Heart, Lung, and Blood Institute,. J. Vasc. Surg. 2001, 34:730-738.
63. Thompson R.W., Liao S., Curci J.A. Vascular smooth muscle cell apoptosis in abdominal aortic aneurysms. Coron. Artery Dis. 1997, 8:623-631.
64. Sakalihasan N., Delvenne P., Nusgens B.V., et al. Activated forms of MMP2 and MMP9 in abdominal aortic aneurysms. J. Vasc. Surg. 1996, 24:127-133.
65. Longo G.M., Buda S.J., Fiotta N., et al. MMP-12 has a role in abdominal aortic aneurysms in mice. Surgery 2005, 137:457-462.
66. Zhang S., Zhong B., Chen M., et al. Epigenetic reprogramming reverses the malignant epigenotype of the MMP/TIMP axis genes in tumor cells. Int. J. Cancer J. Int. du cancer 2014, 134:1583-1594.
67. Stenvinkel P., Karimi M., Johansson S., et al. Impact of inflammation on epigenetic DNA methylation - a novel risk factor for cardiovascular disease?. J. Intern. Med. 2007, 261:488-499.
68. Fuggle N.R., Howe F.A., Allen R.L., et al. New insights into the impact of neuro-inflammation in rheumatoid arthritis. Front. Neurosci. 2014, 8:357.
69. Pereira I.T., Ramos E.A., Costa E.T., et al. Fibronectin affects transient MMP2 gene expression through DNA demethylation changes in non-invasive breast cancer cell lines. PLoS One 2014, 9. e105806.
70. Yuan C., Zhang L., Gao Y., et al. DNA demethylation at the promoter region enhances the expression of MMP-in ectopic endometrial stromal cells of endometriosis. Xi bao yu fen zi mian yi xue za zhi = Chin. J. Cell. Mol. Immunol. 2014, 30:1258-1261.
71. Liu Y., Aryee M.J., Padyukov L., et al. Epigenome-wide association data implicate DNA methylation as an intermediary of genetic risk in rheumatoid arthritis. Nat. Biotechnol. 2013, 31:142-147.
72. St-Pierre Y., Van Themsche C., Esteve P.O. Emerging features in the regulation of MMP-gene expression for the development of novel molecular targets and therapeutic strategies, current drug targets. Inflamm. Allergy 2003, 2:206-215.
73. Xue M., Le N.T., Jackson C.J. Targeting matrix metalloproteases to improve cutaneous wound healing. Expert Opin. Ther. Targets 2006, 10:143-155.
74. Amar S., Engelke M. Periodontal innate immune mechanisms relevant to atherosclerosis. Mol. Oral Microbiol. 2014, 30(3):171-185.
75. Parks W.C., Wilson C.L., Lopez-Boado Y.S. Matrix metalloproteinases as modulators of inflammation and innate immunity. Nat. Rev. Immunol. 2004, 4:617-629.
76. Golledge J., Norman P.E. Atherosclerosis and abdominal aortic aneurysm: cause, response, or common risk factors?, Arteriosclerosis. Thromb. Vasc. Biol. 2010, 30:1075-1077.
77. Shimizu K., Mitchell R.N., Libby P. Inflammation and cellular immune responses in abdominal aortic aneurysms, Arteriosclerosis. Thromb. Vasc. Biol. 2006, 26:987-994.
78. Golledge J., Karan M., Moran C.S., et al. Reduced expansion rate of abdominal aortic aneurysms in patients with diabetes may be related to aberrant monocyte-matrix interactions. Eur. Heart J. 2008, 29:665-672.
79. Samadzadeh K.M., Chun K.C., Nguyen A.T., et al. Monocyte activity is linked with abdominal aortic aneurysm diameter. J. Surg. Res. 2014, 190:328-334.
80. Chatzizisis Y.S., Coskun A.U., Jonas M., et al. Role of endothelial shear stress in the natural history of coronary atherosclerosis and vascular remodeling: molecular, cellular, and vascular behavior. J. Am. Coll. Cardiol. 2007, 49:2379-2393.
81. Cutolo M., Paolino S., Pizzorni C. Possible contribution of chronic inflammation in the induction of cancer in rheumatic diseases. Clin. Exp. Rheumatol. 2014, 32:839-847.
82. Gunawardhana L.P., Gibson P.G., Simpson J.L., et al. Characteristic DNA methylation profiles in peripheral blood monocytes are associated with inflammatory phenotypes of asthma. Epigenet. Off. J. DNA Methylation Soc. 2014, 9:1302-1316.
83. Nordon I.M., Hinchliffe R.J., Loftus I.M., et al. Pathophysiology and epidemiology of abdominal aortic aneurysms, nature reviews. Cardiology 2011, 8:92-102.
84. Cornuz J., Sidoti Pinto C., Tevaearai H., et al. Risk factors for asymptomatic abdominal aortic aneurysm: systematic review and meta-analysis of population-based screening studies. Eur. J. Public Health 2004, 14:343-349.
85. Sweeting M.J., Thompson S.G., Brown L.C., et al. Meta-analysis of individual patient data to examine factors affecting growth and rupture of small abdominal aortic aneurysms. Br. J. Surg. 2012, 99:655-665.
86. Norman P.E., Curci J.A. Understanding the effects of tobacco smoke on the pathogenesis of aortic aneurysm, Arteriosclerosis. Thromb. Vasc. Biol. 2013, 33:1473-1477.
87. Wan E.S., Qiu W., Baccarelli A., et al. Cigarette smoking behaviors and time since quitting are associated with differential DNA methylation across the human genome. Hum. Mol. Genet. 2012, 21:3073-3082.
88. Lee K.W., Pausova Z. Cigarette smoking and DNA methylation. Front. Genet. 2013, 4:132.
89. Bergoeing M.P., Arif B., Hackmann A.E., et al. Cigarette smoking increases aortic dilatation without affecting matrix metalloproteinase-and -12 expression in a modified mouse model of aneurysm formation. J. Vasc. Surg. 2007, 45:1217-1227.
90. Horvath S. DNA methylation age of human tissues and cell types. Genome Biol. 2013, 14. R115.
91. Zykovich A., Hubbard A., Flynn J.M., et al. Genome-wide DNA methylation changes with age in disease-free human skeletal muscle. Aging Cell 2014, 13:360-366.
92. Johnson A.A., Akman K., Calimport S.R., et al. The role of DNA methylation in aging, rejuvenation, and age-related disease,. Rejuvenation Res. 2012, 15:483-494.
93. Guay S.P., Legare C., Houde A.A., et al. Acetylsalicylic acid, aging and coronary artery disease are associated with ABCA1 DNA methylation in men. Clin. Epigenet. 2014, 6:14.
94. Alcazar O., Achberger S., Aldrich W., et al. Epigenetic regulation by decitabine of melanoma differentiation in vitro and in vivo. Int. J. Cancer J. Int. du cancer 2012, 131:18-29.
95. Chouliaras L., van den Hove D.L., Kenis G., et al. Histone deacetylase 2 in the mouse hippocampus: attenuation of age-related increase by caloric restriction. Curr. Alzheimer Res. 2013, 10:868-876.
96. Martin S.L., Hardy T.M., Tollefsbol T.O. Medicinal chemistry of the epigenetic diet and caloric restriction. Curr. Med. Chem. 2013, 20:4050-4059.
97. Shukeir N., Stefanska B., Parashar S., et al. Pharmacological methyl group donors block skeletal metastasis in vitro and in vivo. Br. J. Pharmacol. 2015, [Epub ahead of print]. 10.1111/bph.13102.